NCT01295151 SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. Status COMPLETED Phase PHASE4
NCT01282528 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Status UNKNOWN Phase PHASE4
NCT01256489 Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) Status WITHDRAWN Phase PHASE1/PHASE2
NCT01245361 A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit Status COMPLETED Phase NA
NCT01220518 Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) Status COMPLETED Phase PHASE1
NCT01217086 Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) Status COMPLETED Phase PHASE3
NCT01190839 A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence Status TERMINATED Phase PHASE3
NCT01177800 A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis Status COMPLETED Phase PHASE3
NCT01148901 Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) Status WITHDRAWN Phase PHASE4
NCT01144143 Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab Status COMPLETED Phase PHASE4
NCT00988832 An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066) Status COMPLETED Phase N/A
NCT00984568 Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553) Status TERMINATED Phase PHASE3
NCT00936143 Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00897312 Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease Status TERMINATED Phase N/A
NCT00896168 An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00844805 Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) Status COMPLETED Phase PHASE3
NCT00840957 Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis Status COMPLETED Phase N/A